Loading clinical trials...
Loading clinical trials...
A Phase IIA, Open-Label, Safety and Pharmacokinetic Study of Diclofenac Capsules in Pediatric Subjects 6 to <17 Years of Age With Mild to Moderate Acute Postoperative Pain Following Elective Surgery
Conditions
Interventions
Diclofenac Capsules low dose
Diclofenac Capsules high dose
Locations
5
United States
Sheffield, Alabama, United States
Little Rock, Arkansas, United States
Durham, North Carolina, United States
Oklahoma City, Oklahoma, United States
Philadelphia, Pennsylvania, United States
Start Date
May 1, 2015
Primary Completion Date
April 1, 2016
Completion Date
April 19, 2016
Last Updated
July 13, 2017
NCT06528288
NCT03230565
NCT06358040
NCT06576830
NCT05991453
NCT04144972
Lead Sponsor
Iroko Pharmaceuticals, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions